Year: 2025
Type: editorial
Abstract: Community-acquired pneumonia (CAP) is a leading cause of hospitalization and mortality worldwide, necessitating continuous advancements in its management.As antimicrobial resistance rises and treatment complexities grow, researchers are exploring innovative therapeutic strategies to enhance patient outcomes.From evaluating the efficacy of adjunct therapies to investigating novel antibiotics and optimizing dosing regimens, recent studies have shed light on critical aspects of CAP treatment.The aim of this commentary is to highlight key emerging studies on adjunctive therapies, new antimicrobial agents, innovative dosing strategies and machine learning tools in order to demonstrate the expanding potential for a more individualized approach to the treatment of CAP.These developments collectively challenge the longstanding one-size-fits-all paradigm and invite a redefinition of how pharmacological care is delivered in this common yet heterogeneous condition.
DOI: 10.1002/bcp.70107
Authors: Matija Duda, Ivan Damjanović, Robert Likić
Institutions: University of Zagreb, University Hospital Centre Zagreb
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4410716575